Arizona ADHD Center Opens New Scottsdale Clinic 28.01.2025
Arizona ADHD Center Expands with New Scottsdale Clinic, Enhancing ADHD Diagnosis and Treatment Arizona ADHD Center, a premier medical and behavioral health clinic specializing in ADHD diagnosis, treatment, and ongoing…
Nanoemulsions Market Report 2024-2030: Analysis & Forecasts by Drug Class
Global Nanoemulsions Market Report 2024-2030: Growth Trends, Applications, and Forecasts Nanoemulsions – Global Strategic Business Report,” providing an in-depth analysis of the expanding nanoemulsions market. This report examines industry trends,…
JCR Pharmaceuticals to Showcase at the 21st Annual WORLDSymposium™ 2025
JCR Pharmaceuticals to Present at the 21st Annual WORLDSymposium™ 2025 in San Diego JCR Pharmaceuticals Co., Ltd. (TSE 4552), a leading global specialty pharmaceutical company, has announced its participation in…
Modella AI’s PathChat Co-Pilot Earns FDA Breakthrough Device Status
Modella AI, a leader in generative and agentic artificial intelligence for biomedicine, has announced that its advanced generative AI co-pilot, PathChat DX, has been granted Breakthrough Device Designation by the…
GeminiBio Appoints Matt Stober to Board of Directors
GeminiBio Appoints Matt Stober to Board of Directors Gemini Bioproducts, LLC (“GeminiBio”), a leading supplier of raw materials to the biopharmaceutical and advanced therapy industries, has announced the appointment of…
Trilobio Unveils Groundbreaking Whole-Laboratory Automation Platform at SLAS2025
Trilobio Unveils Revolutionary Whole-Lab Automation Platform at SLAS2025: A Game-Changer for Life Science Research San Diego, CA – January 25-29, 2025 – Trilobio, a pioneering developer of whole-laboratory automation solutions,…
Sage Therapeutics Rejects Biogen’s Acquisition Proposal, Explores Strategic Alternatives
Sage Therapeutics Explores Strategic Alternatives and Rejects Biogen’s Acquisition Offer Sage Therapeutics, Inc. (Nasdaq: SAGE), a leader in brain health therapeutics, announced today that its Board of Directors has initiated…
Inventia Life Science Launches RASTRUM™ Allegro to Revolutionize 3D Cell Culture in Drug Discovery
Inventia Life Science Unveils RASTRUM™ Allegro to Transform 3D Cell Culture in Drug Discovery and Disease Research Inventia Life Science, a leader in 3D cell culture technologies, has announced the…
Genentech’s Itovebi Demonstrates Survival Benefit in HR-Positive Advanced Breast Cancer
Genentech Announces Positive OS Results for Itovebi in Advanced HR-Positive Breast Cancer Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), has announced positive topline results from…
Cannabis Pharmaceuticals Market 2024-2034: Focus on Sativex, Cesamet, Marinol, Epidiolex – ResearchAndMarkets.com
Cannabis Pharmaceuticals Market 2024-2034: Focus on Sativex, Cesamet, Marinol, Epidiolex – ResearchAndMarkets.com The global cannabis pharmaceuticals market, valued at USD 3.46 billion in 2023, is expected to experience remarkable growth,…
ENHERTU® Approved in U.S. for HER2-Low Metastatic Breast Cancer Post-Endocrine Therapy
ENHERTU® Approved in U.S. for HER2-Low Metastatic Breast Cancer Post-Endocrine Therapy Daiichi Sankyo (TSE: 4568) and AstraZeneca’s (LSE/STO/Nasdaq: AZN) ENHERTU® (fam-trastuzumab deruxtecan-nxki) has been approved in the U.S. for the treatment…
Ncardia Launches Ncyte® Heart in a Box for Precision Cardiovascular Research – Release 1
Ncardia, a global leader in human induced pluripotent stem cell (hiPSC) technology, has officially launched the Ncyte® Heart in a Box, an innovative 3D model of cardiac microtissue designed to…